Sorafenib for treating advanced hepatocellular carcinoma

Equality Impact Assessment (Guidance development) (PDF 249 KB)

Final appraisal determination

Final appraisal determination document (PDF 123 KB)

Committee papers (PDF 615 KB)

Public committee slides (PDF 923 KB)

Draft guidance: 2

Committee papers (PDF 1.18 MB)

Appraisal consultation document (PDF 418 KB)

Draft guidance: 1

Appraisal consultation document (PDF 100 KB)

Committee papers (PDF 4.48 MB)

TA189 : Appeal letter (PDF 631 KB)

: Appeal letter (PDF 627 KB)

: Scrutiny letter (PDF 265 KB)

: Response to scrutiny letter (PDF 232 KB)

: Final scrutiny letter (PDF 242 KB)

Appeal decision TA189 (PDF 333 KB)

Final appraisal determination document TA189  (PDF 134 KB)

Consultation document TA189 ACD2 - 09 September 2009 (PDF 131 KB)

Committee papers TA189 ACD2 - 09 September 2009 (PDF 712 KB)

Committee papers C&C responses - TA189 ACD2 - 09 September 2009 (PDF 222 KB)

Consultation document TA189 ACD1 06 May 2009 (PDF 117 KB)

Committee papers TA189 ACD1 06 May 2009 (PDF 2.17 MB)

Committee papers Company submissions - TA189 ACD1 06 May 2009 (PDF 1.42 MB)

Committee papers C&C submissions - TA189 ACD1 06 May 2009 (PDF 133 KB)

Committee papers Expert Statements - TA189 ACD1 06 May 2009 (PDF 868 KB)

NICE's response to comments on the draft scope and provisional matrix TA189 27 October 2008 (PDF 20 KB)

Final scope TA189 27 October 2008 (PDF 28 KB)

Final matrix TA189 27 October 2008 (PDF 34 KB)